CDXS Codexis Inc

Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report first quarter 2017 financial results after market close on Tuesday, May 9, 2017. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.

Live Call:		U.S.	855 890 8665
		International	720 634 2938
		Passcode	14067412
Live Webcast:		Codexis IR Website
		The webcast will be archived for 30 days.
Replay:		U.S.	855 859 2056
		International	404 537 3406
		Passcode	14067412
		The replay will be available for 48 hours

About Codexis, Inc.Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.

CONTACTS: 

InvestorsLHAJody Cain, 310 691 7100 jcain@lhai.com